Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Post by jojomarchon Dec 28, 2017 5:58pm
204 Views
Post# 27241313

The blame

The blameneeds to be shared bettween the manipulators that inhabit  the  venture exchange  and  Roger . I think he  messed up the timelines  . When your in business you have to understand your environment  , even in biotech  , you can't play hot patato with the blame by saying it's the fault of HC , the FDA , the doctors , the hospital , the patients , etc... You have to  calculate these factors with a reasonable percentage of error , i don't think he did when he gave interviews in 2014 and stated the timelines in order to reach commercialization . I'm 100% sure he understands this business better than me so he either has amazing science or he's just having fun on our dime . TLT basically released news every 2 weeks in 2017  and the market says 24 pennies . If  Roger has the science i have come to believe he should , in all honesty , be able to explain this to major players in this field of oncology ...it should be straight foward . TLT will be entering a multi centre Ph 2 so they need large capital and he's knowed this since this summer at least . If Roger hasn't talked to big pharma or at least OPKO he's a fool . If he issues 40 million shares + 40 million warrants then i'm the fool . 

GLTA
Bullboard Posts